Kathryn W Kyle sold $26k of LH
EVP, Chief Legal Officer at LABORATORY CORP OF AMERICA HOLDINGS. 92 shares at an average of $286.19, traded Jul 2, 2026, filed Jul 6, 2026.
Score components
- +15RoleOfficer
- +5Trade size$26k at market
- 0Share of holdings soldSold 2.3% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000920148-26-000152, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | MOption exercise Common Stock10b5-1 | +256 | - | - | 4,069 | Jul 6, 2026 |
| Jul 1, 2026 | FTax withholding Common Stock10b5-1 | -73 | $283.88 | $21k | 3,996 | Jul 6, 2026 |
| Jul 2, 2026 | SOpen-market sale Common Stock10b5-1 | -92 | $286.19 | $26k | 3,904 | Jul 6, 2026 |
| Jul 1, 2026 | MOption exercise Restricted Stock Unitderivative10b5-1 | -256 | $0.00 | $0 | 2,008 | Jul 6, 2026 |
Related signals
Other insiders at LABORATORY CORP OF AMERICA HOLDINGS and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 44Moderate | LABORATORY CORP OF AMERICA HOLDINGS | Kerrii B Anderson director | $954k 3,000 shares | -31% | |
| 45Moderate | LABORATORY CORP OF AMERICA HOLDINGS | Adam H Schechter President & CEO | $1.5M 4,669 shares | -4% | |
| 49Moderate | LABORATORY CORP OF AMERICA HOLDINGS | Amy B. Summy EVP, Chief Marketing Officer | $283k 924 shares | -12% | |
| 52Moderate | LABORATORY CORP OF AMERICA HOLDINGS | Peter J Wilkinson SVP, Chief Accounting Officer | $439k 1,420 shares | -77% | |
| 0Weak | LABORATORY CORP OF AMERICA HOLDINGS | Bryan T Vaughn EVP and President, Diagnostics | $67k 234 shares | -3% | |
| 12Weak | LABORATORY CORP OF AMERICA HOLDINGS | Kathryn W Kyle EVP, Chief Legal Officer | $201k 762 shares | -17% | |
| 30Weak | LABORATORY CORP OF AMERICA HOLDINGS | Adam H Schechter President & CEO | $1.5M 5,903 shares | -5% | |
| 20Weak | LABORATORY CORP OF AMERICA HOLDINGS | Jonathan C Meltzer EVP, Operations | $224k 839 shares | -19% | |
| 30Weak | LABORATORY CORP OF AMERICA HOLDINGS | Peter J Wilkinson SVP, Chief Accounting Officer | $436k 1,633 shares | -47% | |
| 65Notable | LABORATORY CORP OF AMERICA HOLDINGS | Adam H Schechter President & CEO | $2.4M 8,705 shares | -10% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.